Search for: "Endo Pharmaceutical"
Results 41 - 60
of 255
Sort by Relevance
|
Sort by Date
18 Nov 2019, 4:24 am
In recent lawsuits, the defendants have included McKesson Corporation, Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, Covidien, Johnson & Johnson, CVS, Walgreens, and Rite Aid. [read post]
12 Aug 2019, 6:37 am
In June 2019, Attorney General Becerra settled with Endo Pharmaceuticals, securing an eight-year injunction against further pay-for delay agreements and payment of $760,000. [read post]
10 Jun 2019, 10:59 am
Slatery III has filed suit against Endo Pharmaceuticals and Endo Health Solutions Inc. [read post]
16 May 2019, 8:15 am
(collectively, “Actavis”) failed to prove by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals and Mallinckrodt LLC (collectively, “Endo”) were invalid. [read post]
16 May 2019, 8:15 am
(collectively, “Actavis”) failed to prove by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals and Mallinckrodt LLC (collectively, “Endo”) were invalid. [read post]
12 May 2019, 11:00 am
On May 18, 2015 Endo announced that it would be acquiring Par Pharmaceutical, another generic drug company for over $8 billion. [read post]
12 May 2019, 11:00 am
On May 18, 2015 Endo announced that it would be acquiring Par Pharmaceutical, another generic drug company for over $8 billion. [read post]
6 May 2019, 9:58 pm
Noonan -- Last Friday, the Federal Circuit affirmed a decision by the District Court that Defendants Actavis LLC and Teva Pharmaceuticals did not show by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals Inc. and Mallinckrodt LLC were obvious, in Endo Pharmaceuticals Inc. v. [read post]
1 Apr 2019, 9:59 pm
By Donald Zuhn -- Last week, in Endo Pharmaceuticals Inc. v. [read post]
28 Mar 2019, 11:01 am
See Endo Pharms. [read post]
28 Mar 2019, 9:07 am
Endo Pharmaceuticals Inc. v. [read post]
30 Jan 2019, 5:06 am
Besides Purdue Pharma LP, the list of defendants named in NYC’s suit includes long-time opioid manufacturers Allergan Plc, Endo International Plc, Johnson & Johnson, and Teva Pharmaceutical Industries Ltd., and distributors AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp. [read post]
23 Jan 2019, 9:30 pm
In a rare instance of such a withdrawal decision, FDA recently requested the removal of Opana ER—a painkilling opioid manufactured and marketed by Endo Pharmaceuticals—from the pharmaceutical market. [read post]
31 Oct 2018, 5:09 pm
As I noted here, Allergan, Teva Pharmaceuticals, and Endo International (whose Par Pharmaceuticals unit is caught up in the investigation) – all three companies that have been identified by name in connection with the alleged generic drug price-fixing conspiracy – previously were hit with securities class action lawsuit related to the price-fixing investigation. [read post]
19 Aug 2018, 9:59 pm
By Donald Zuhn -- Last month, in Endo Pharmaceuticals Solutions, Inc. v. [read post]
17 Jul 2018, 9:28 am
Endo Pharms. [read post]
13 Jul 2018, 5:48 pm
We agree with Endo. [read post]
1 Jun 2018, 7:21 am
" Endo Pharmaceuticals Inc. v. [read post]
19 Apr 2018, 12:00 am
Endo acquired Par Pharmaceuticals (“Par”) in 2015. [read post]
6 Apr 2018, 6:38 am
In continuing coverage, TIME reports Endo Pharmaceuticals announced that it is voluntarily withdrawing Opana ER (oxymorphone hydrochloride) from the market. [read post]
